REFERENCES 1. Chen, D, Zhao, M, Mundy, G R(2004)Bone Morphogenic Proteins. Growth Factors22(4)233-241 2. Kan, L.X., Hu, M, Gomes, W.A., Kessler, J. A(2004) Transgenic mice overexpressing BMP4 Develop Fibrodysplasia Ossificans Progressiva(FOP)Like Phenotype. Am J Pathol 165(4): 1107-1115 3. Kaplan, F.S., Glaser, D L,, Pignolo, R.J., Shore, E.M. (2007)A new era for fibrodysplasia ossificans progressiva: a drugable target for the second skeleton. Expert Opin Biol Ther 7(5): 705-712 4. Kaplan, F.S., Le Merrer, M, Glaser, D L, Pignolo, R.J., Goldsby, R.E., et al (2008) Fibrodysplasia Ossificans Progressiva. Best Pract Res Clin Rheumatol 22(1):191-205 5. Kaplan, F.S., Xu, M.Q., Glaser, D L, Collins, F, Connor, M, et al. (2008) Early Diagnosis of Fibrodysplasia Ossificans Progressiva. Pediatrics 121(5): 1295 1300 6. Lee, D.Y., Cho, T.J., Lee, H.R., Park, M.S., Chung, C. Y, Choi, I H (2009) ACVRI Gene Mutation in Sporad ic Korean Patients with Fibrodysplasia Ossificans Progressiva. J Korean Med Sci 24: 433-7. doi 103346/kms.2009243433 7. Petrie, K.A., Lee, W.H., Bullock, A N, Pointon, J.J., Smith, R, et al.(2009) Novel Mutations in ACVRI Results in Atypical Features in Two Fibrodysplasia Ossificans Progressiva Patients. PLOS ONE 43): e5005 doi 10. 1371/journal. phone. 005005 8. Shore, E.M., Kaplan, FS(2008 )Insights from a Rare Genetic Disorder of Extra skeletal Bone Formation, Fibrodisplasia Ossificans Progressiva. Bone 43(3): 427- 433.doi:10.1016/bone.200805013 9. Yu, P B, Deng, D.Y., Lai, C.S., Hong, CC, Cuny, G D, et al.(2008) BMP type I receptor inhibition reduces heterotopic ossification. Nat Med 14: 1363-1369 10. ACVRI. December, 21, 2009). Retrieved December 29, 2009, from Genetics Home refer Websitehttp:ghrnim.nihgov/gene=acvr1REFERENCES 1. Chen, D., Zhao, M., Mundy, G.R. (2004) Bone Morphogenic Proteins. Growth Factors 22 (4): 233-241. 2. Kan, L.X., Hu, M., Gomes, W.A., Kessler, J.A. (2004) Transgenic mice overexpressing BMP4 Develop Fibrodysplasia Ossificans Progressiva (FOP) Like Phenotype. Am J Pathol 165 (4): 1107-1115 3. Kaplan, F.S., Glaser, D.L., Pignolo, R.J., Shore, E.M. (2007) A new era for firbrodysplasia ossificans progressiva: a drugable target for the second skeleton. Expert Opin Biol Ther 7(5): 705-712 4. Kaplan, F.S., Le Merrer, M., Glaser, D.L., Pignolo, R.J., Goldsby, R.E., et al. (2008) Fibrodysplasia Ossificans Progressiva. Best Pract Res Clin Rheumatol 22(1): 191-205. 5. Kaplan, F.S., Xu, M.Q., Glaser, D.L., Collins, F., Connor, M., et al. (2008) Early Diagnosis of Fibrodysplasia Ossificans Progressiva. Pediatrics 121 (5): 1295- 1300 6. Lee, D.Y., Cho, T.J., Lee, H.R., Park, M.S., Chung, C.Y., Choi, I.H. (2009) ACVR1 Gene Mutation in Sporadic Korean Patients with Fibrodysplasia Ossificans Progressiva. J Korean Med Sci 24: 433-7. doi: 10.3346/jkms.2009.24.3.433 7. Petrie, K.A., Lee, W.H., Bullock, A.N., Pointon, J.J., Smith, R., et al. (2009) Novel Mutations in ACVR1 Results in Atypical Features in Two Fibrodysplasia Ossificans Progressiva Patients. PLoS ONE 4(3): e5005. doi: 10.1371/journal.phone.005005 8. Shore, E.M., Kaplan, F.S. (2008) Insights from a Rare Genetic Disorder of Extra￾skeletal Bone Formation, Fibrodisplasia Ossificans Progressiva. Bone 43(3): 427- 433. doi: 10.1016/j.bone.2008.05.013. 9. Yu, P.B., Deng, D.Y., Lai, C.S., Hong, C.C., Cuny, G.D., et al. (2008) BMP type I receptor inhibition reduces heterotopic ossification . Nat Med 14: 1363-1369. 10. ACVR1 . (December, 21, 2009). Retrieved December 29, 2009, from Genetics Home Reference. Website: http://ghr.nlm.nih.gov/gene=acvr1